Clinical Trial Update: Trial Evaluating Combined Chemotherapy in Patients With Metastatic Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a combined chemotherapy regimen in metastatic pancreatic adenocarcinoma has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Not disclosed

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Metastatic Pancreatic Adenocarcinoma | Phase 2 | Status: COMPLETED